Xanthine oxidase and uric acid in atrial fibrillation

Xanthine oxidase and uric acid in atrial fibrillation

Bibliographic Details
Main Authors:	PANAGIOTIS eKORANTZOPOULOS, KONSTANTINOS eLETSAS, TONG eLIU
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2012-05-01
Series:	Frontiers in Physiology
Subjects:	Atrial Fibrillation Oxidative Stress Uric Acid Xanthine Oxidase ATRIAL REMODELING
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphys.2012.00150/full

Similar Items

Inflammation and atrial fibrillation: A comprehensive review
by: Panagiotis Korantzopoulos, et al.
Published: (2018-08-01)

Adenosine deaminase, xanthine oxidase, uric acid, and nitric oxide metabolism in the pathogenesis of disease in patients with colon polyps
by: Rafet Mete, et al.
Published: (2014-03-01)

The effect of chayote leaves (Sechium edule)’s flavonoid fraction on the reduction of the serum uric acid levels through the inhibition of xanthine oxidase activity
by: Diah Pitaloka Putri, et al.
Published: (2021-10-01)

The Role of Atrial Remodelling in Atrial Fibrillation
by: Ignatius Yansen, et al.
Published: (2013-06-01)

Uric acid and incident atrial fibrillation of 14 years population‐based cohort study: The Suita Study
by: Takashi Kobayashi, et al.
Published: (2021-10-01)

Does Serum Uric Acid Status Influence the Association Between Left Atrium Diameter and Atrial Fibrillation in Hypertension Patients?
by: Tesfaldet H. Hidru, et al.
Published: (2020-11-01)

Antihyperurisemic Activity of Aqueous Celery Infusion by Xanthine Oxidase Enzyme Inhibition
by: Atiqoh Zummah, et al.
Published: (2018-12-01)

Reduction of Conduction Velocity in Patients with Atrial Fibrillation
by: Annejet Heida, et al.
Published: (2021-06-01)

The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation
by: Yawen Deng, et al.
Published: (2021-02-01)

Impact of right atrial structural remodeling on recurrence after ablation for atrial fibrillation
by: Takahito Takagi, et al.
Published: (2021-06-01)

Attenuating Effects of Anti-Arrhythmic Agents on Changes in Fibrillation Cycle Length in Very Early Phase Paroxysmal Atrial Fibrillation —Spectral Analysis of Fibrillation Waves in Surface ECG—
by: Hidehira Fukaya, MD, et al.
Published: (2009-01-01)

PENGHAMBATAN AKTIVITAS XANTHINE OXIDASE OLEH EKSTRAK ETANOL AKAR SAMBILOTO (Andrographis paniculata, Ness) SECARA IN VITRO
by: Ulfah Septianingsih, et al.
Published: (2012-11-01)

Roles and significance of CaMKⅡ and PLB in atrial remodeling in patients with atrial fibrillation
by: CAO Zhezhe, et al.
Published: (2019-02-01)

Lead-elevated activity of xanthine oxidase in lead-exposed workers
by: Sławomir Kasperczyk, et al.
Published: (2013-04-01)

Old drug, new indication: Olsalazine sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity
by: Yanfen Niu, et al.
Published: (2017-11-01)

Rapid Atrial Pacing Promotes Atrial Fibrillation Substrate in Unanesthetized Instrumented Rats
by: Wesam Mulla, et al.
Published: (2019-09-01)

Atrial matrix remodeling in atrial fibrillation patients with aortic stenosis
by: Mariana Fragão-Marques, et al.
Published: (2020-10-01)

Some opportunities of using xanthine oxidase inhibitors
by: O. V. Zhelyabina, et al.
Published: (2019-03-01)

Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study
by: Sumito Sunagawa, et al.
Published: (2019-01-01)

Xanthine Oxidase Inhibitory Activity of a Plectranthus saccatus aqueous extract
by: Caldeira F, et al.
Published: (2016-12-01)

Inotropic myocardial function dynamics in patients with recurrent atrial fibrillation
by: N. E. Gaidamakina, et al.
Published: (2006-06-01)

Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1
by: Dool-Ri Oh, et al.
Published: (2019-01-01)

New Strategies for the Treatment of Atrial Fibrillation
by: Norbert Jost, et al.
Published: (2021-09-01)

Determinants of development and preservation of atrial fibrillation at thyrotoxicosis
Published: (2013-03-01)

Persistence of left atrial abnormalities despite left atrial volume normalization after successful ablation of atrial fibrillation
by: Hiroshi Kawakami, et al.
Published: (2021-10-01)

Xanthine oxidase inhibition in SARS-CoV-2 infection: the mechanism and potency of allopurinol and febuxostat in COVID-19 management
by: Irandi Putra Pratomo, et al.
Published: (2020-11-01)

Reverse atrial remodeling and resolution of mitral regurgitation after rhythm control in atrial fibrillation: A case report
by: Shaya Yaanallah Al Qahtani, et al.
Published: (2019-01-01)

Left atrial remodeling: Regional differences between paroxysmal and persistent atrial fibrillation
by: Rikitake Kogawa, MD, et al.
Published: (2017-10-01)

The possible mechanism of hydroxytyrosol on reducing uric acid levels
by: Yin Wan, et al.
Published: (2018-03-01)

Higher Incidence of Atrial Fibrillation in Left Ventricular-to-Right Atrial Shunt Patients
by: Hongda Chou, et al.
Published: (2020-12-01)

MicroRNA as a novel player in atrial fibrillation
by: Siyi eFu, et al.
Published: (2014-04-01)

Imaging Techniques for the Study of Fibrosis in Atrial Fibrillation Ablation: From Molecular Mechanisms to Therapeutical Perspectives
by: Francesco De Sensi, et al.
Published: (2021-05-01)

Plumbagin can potently enhance the activity of xanthine oxidase: in vitro, in vivo and in silico studies
by: Liang Yue, et al.
Published: (2021-07-01)

The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis
by: Jiangrong Wang, et al.
Published: (2019-02-01)

Left atrial scar identification and quantification in sinus rhythm and atrial fibrillation
by: James Mannion, et al.
Published: (2020-12-01)

An improved amperometric determination of xanthine with xanthine oxidase nanoparticles for testing of fish meat freshness
by: Archana Joon, et al.
Published: (2021-08-01)

Evidence for Inflammation as a Driver of Atrial Fibrillation
by: Xiaoxu Zhou, et al.
Published: (2020-04-01)

Left Atrial Structural Remodelling in Non-Valvular Atrial Fibrillation: What Have We Learnt from CMR?
by: Mariana Floria, et al.
Published: (2020-03-01)

The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights
by: Loryn J. Bohne, et al.
Published: (2019-02-01)

Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions
by: Paweł Muszyński, et al.
Published: (2021-05-01)